Ameriprise’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Ameriprise’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,106	Closed	–	–	3823
2016 Q4	$0	Sell	13,106 -29,440	-69%	–	﹤0.01%	4036
2016 Q3	$0	Sell	42,546 -50,200	-54%	–	﹤0.01%	3939
2016 Q2	$1K	Sell	92,746 -18,140	-16%	-$196	﹤0.01%	3759
2016 Q1	$40K	Sell	110,886 -55,428	-33%	-$20K	﹤0.01%	3685
2015 Q4	$121K	Sell	166,314 -16,780	-9%	-$14.9K	﹤0.01%	3722
2015 Q3	$150K	Sell	183,094 -54,757	-23%	-$61K	﹤0.01%	3687
2015 Q2	$362K	Buy	237,851 +49,654	+26%	+$118K	﹤0.01%	3576
2015 Q1	$460K	Buy	+188,197	New	+$741K	﹤0.01%	3237
2014 Q4	–	Sell	-80	Closed	-$1K	–	5122
2014 Q3	$1K	Hold	80	–	–	﹤0.01%	5687
2014 Q2	$1K	Buy	+80	New	+$1.39K	﹤0.01%	5478

Ameriprise's RCPI Position: Q1 2017 in Review

Ameriprise sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q1 2017, closing a stake of 13,106 shares.

Ameriprise first reported a position in RCPI in Q2 2014 and held it in 10 quarters. The position peaked at $460K in Q1 2015. 0 funds tracked by Wall St. Rank hold RCPI as of Q1 2017.

Ameriprise reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q1 2017 after selling out during the quarter.
Ameriprise sold 13,106 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q1 2017.
Ameriprise first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 10 quarters.
Ameriprise's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $460K in Q1 2015.
0 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q1 2017.

Based on Ameriprise's 13F filing for Q1 2017, filed 5 May 2017.